Oncolytic adenovirus CAdVEC
Term · Oncology and biomedicine · MLC-T-ONC-015627
A genetically modified oncolytic viral strain of human adenovirus (Ad) with potential immunostimulating and antineoplastic activities. Upon intratumoral administration, the oncolytic adenovirus CAdVEC selectively infects and replicates in tumor cells, leading to tumor cell lysis. Additionally, CAdVEC has been genetically modified to express currently undisclosed immunomodulatory molecules that may enhance the anti-tumor effects of endogenous T lymphocytes as well as adoptively transferred chimeric antigen receptor (CAR) T cells.
| Identifier | MLC-T-ONC-015627 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | CAdVEC; CAd-VEC |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015627",
"term": "Oncolytic adenovirus CAdVEC",
"field": "Oncology and biomedicine",
"definition": "A genetically modified oncolytic viral strain of human adenovirus (Ad) with potential immunostimulating and antineoplastic activities. Upon intratumoral administration, the oncolytic adenovirus CAdVEC selectively infects and replicates in tumor cells, leading to tumor cell lysis. Additionally, CAdVEC has been genetically modified to express currently undisclosed immunomodulatory molecules that may enhance the anti-tumor effects of endogenous T lymphocytes as well as adoptively transferred chimeric antigen receptor (CAR) T cells.",
"synonyms": [
"CAdVEC",
"CAd-VEC"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/oncolytic-adenovirus-cadvec/"
}
Record 12,186 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.